MedPath

A blended face-to-face and smartphone intervention for suicide prevention in the construction industry (MATESMobile): protocol for a randomized controlled trial with MATES in Construction.

Not Applicable
Conditions
Suicide
health literacy
Mental Health - Suicide
Registration Number
ACTRN12619000625178
Lead Sponsor
Cbus
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
844
Inclusion Criteria

Participants need to be recruited from a site where MATES is operational. Workers attending GAT will be considered eligible for the study.

Exclusion Criteria

None.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite primary outcomes and Measures <br>1.Socio-demographic data: Survey questions include age, sex and educational levels as collected by the Australian Bureau of Statistics <br>2.Suicide prevention literacy: GAT suicide awareness questionnaire, which asks about suicide knowledge, attitudes, and behaviours<br>3.Help-seeking and help-offering behaviour: General Help-Seeking Questionnaire and the GAT help-seeking and help-offering items.<br><br>[Baseline assessment (a longer survey) prior to the 8 week intervention, followed by smaller assessments at 3, 6 and 12 months. ]
Secondary Outcome Measures
NameTimeMethod
<br>Outcome and Measure<br>1. Suicidal ideation and behaviours: revised version of the Suicidal Behavior Questionnaire-Revised <br>[Baseline assessment (a longer survey) prior to the 8 week intervention, followed by smaller assessments at 3, 6 and 12 months. <br><br>];Outcome and Measure<br>1. Psychological distress : Kessler-6 instrument <br><br>[Baseline assessment (a longer survey) prior to the 8 week intervention, followed by smaller assessments at 3, 6 and 12 months. <br>];Outcome and Measure<br>Psychosocial risks in the workplace: Psychosocial Safety Climate (PSC-12)<br>[Baseline assessment (a longer survey) prior to the 8 week intervention, followed by smaller assessments at 3, 6 and 12 months. <br>]
© Copyright 2025. All Rights Reserved by MedPath